LH * Stock Overview
Provides laboratory services. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Labcorp Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4,101.00 |
| 52 Week High | US$4,370.00 |
| 52 Week Low | US$3,524.01 |
| Beta | 1.04 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -27.59% |
| 5 Year Change | 27.56% |
| Change since IPO | 46.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| LH * | MX Healthcare | MX Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -0.3% |
| 1Y | n/a | -15.3% | -4.0% |
Return vs Industry: Insufficient data to determine how LH * performed against the MX Healthcare industry.
Return vs Market: Insufficient data to determine how LH * performed against the MX Market.
Price Volatility
| LH * volatility | |
|---|---|
| LH * Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 6.1% |
| 10% least volatile stocks in MX Market | 2.7% |
Stable Share Price: LH *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine LH *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 61,975 | Adam Schechter | www.labcorp.com |
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
Labcorp Holdings Inc. Fundamentals Summary
| LH * fundamental statistics | |
|---|---|
| Market cap | Mex$410.55b |
| Earnings (TTM) | Mex$8.92b |
| Revenue (TTM) | Mex$260.37b |
46.0x
P/E Ratio1.6x
P/S RatioIs LH * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LH * income statement (TTM) | |
|---|---|
| Revenue | US$12.71b |
| Cost of Revenue | US$9.16b |
| Gross Profit | US$3.55b |
| Other Expenses | US$3.11b |
| Earnings | US$435.50m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.21 |
| Gross Margin | 27.92% |
| Net Profit Margin | 3.43% |
| Debt/Equity Ratio | 83.2% |
How did LH * perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield56%
Payout RatioDoes LH * pay a reliable dividends?
See LH * dividend history and benchmarks| Labcorp Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Nov 26 2024 |
| Dividend Pay Date | Dec 13 2024 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 19 days |
Does LH * pay a reliable dividends?
See LH * dividend history and benchmarks